Trial intelligence / Profile preview

Hytrin vs Hytrin + Hinechol for lower urinary tract symptoms

KCT0003892Phase 4Not yet recruiting

Sponsor
Il-Yang Pharmaceutical
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of terazosin in Micturition disorder, sponsored by Il-Yang Pharmaceutical. Planned start May 2019; status: not yet recruiting.

02

Drugs

terazosin
03

Conditions

Micturition disorder

Beyond the preview

Go deeper on KCT0003892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call